Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

RENB

Renovaro Inc

Dec 12 • 04:00PM ET

1.72

Dollar change -0.18
Percentage change -9.71	%

Healthcare • Biotechnology • USA • NASD

Peers: ENPH SEDG RUN CSIQ FSLR JKS NOVA AY NEE

| Held by: IWM VTI VXF IWO IWN IWC VTWO RSSL VTWG UWM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.93	Insider Own	51.39%	Shs Outstand	157.62M	Perf Week	19.44%
Market Cap	272.99M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.58%	Shs Float	77.15M	Perf Month	173.06%
Income	-115.69M	PEG	-	EPS next Q	-	Inst Own	9.29%	Short Float	3.92%	Perf Quarter	162.60%
Sales	0.00M	P/S	-	EPS this Y	-	Inst Trans	4.21%	Short Ratio	4.75	Perf Half Y	18.62%
Book/sh	0.62	P/B	2.76	EPS next Y	-	ROA	-128.97%	Short Interest	3.03M	Perf Year	-50.29%
Cash/sh	0.00	P/C	1240.86	EPS next 5Y	-	ROE	-159.75%	52W Range	0.40 - 5.25	Perf YTD	-45.74%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-11.80%	ROI	-117.10%	52W High	-67.24%	Beta	0.64
Dividend TTM	-	Quick Ratio	0.08	Sales past 5Y	0.00%	Gross Margin	-	52W Low	335.44%	ATR (14)	0.23
Dividend Ex-Date	-	Current Ratio	0.08	EPS Y/Y TTM	-39.90%	Oper. Margin	-	RSI (14)	71.15	Volatility	25.96% 21.18%
Employees	25	Debt/Eq	0.04	Sales Y/Y TTM	-	Profit Margin	-	Recom	-	Target Price	-
Option/Short	Yes / No	LT Debt/Eq	0.01	EPS Q/Q	-98.45%	Payout	-	Rel Volume	1.14	Prev Close	1.90
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-	Earnings	-	Avg Volume	637.40K	Price	1.72
SMA20	77.21%	SMA50	134.90%	SMA200	31.81%	Trades		Volume	724,927	Change	-9.71%

Nov-04-24 08:31AM	Renovaro Issues Shareholder Letter and Provides Corporate Update (GlobeNewswire) +15.44%
Oct-17-24 09:15AM	RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing (GlobeNewswire) -20.30%
Oct-16-24 09:28AM	Renovaro Announces Strategic Restructuring and Leadership Transition (GlobeNewswire) +32.01%
Sep-19-24 09:00AM	PersonalAIze and Cube Forge Groundbreaking Partnership to Accelerate AI-Driven Healthcare Platform and Point of Care Diagnostics (GlobeNewswire)
Sep-17-24 09:00AM	Independent Expert Assessment Validates RenovaroCube's Potential as a Groundbreaking AI Platform Starting with Early Cancer Detection (GlobeNewswire) -5.16%
09:00AM	Loading…
Sep-13-24 09:00AM	RenovaroCube to Present Cutting-Edge Cancer Diagnostics Research at European Society for Medical Oncology Congress (GlobeNewswire) +5.51%
Sep-11-24 09:15AM	RenovaroCube Announces Strategic Offering of Up to 20% Ownership (GlobeNewswire)
Jul-26-24 07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
05:30AM	The Junk in Your Index Fund Is Costing You Big-Time (The Wall Street Journal)
Jun-14-24 09:06AM	Renovaro, Inc. Announces $10 million in Equity Committed (GlobeNewswire) +13.10%
May-24-24 09:20AM	Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy (GlobeNewswire) +7.58%
08:45AM	Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032 (GlobeNewswire)
May-16-24 08:53AM	RENB Stock Earnings: Renovaro Biosciences Reported Results for Q3 2024 (InvestorPlace)
Apr-30-24 11:00AM	Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics (GlobeNewswire)
Apr-24-24 09:00AM	RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership (GlobeNewswire)
08:45AM	Loading…
Apr-18-24 08:45AM	Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care (GlobeNewswire)
Mar-04-24 09:00PM	Bragar Eagel & Squire, P.C. Is Investigating Waldencast, Chemours, Trupanion, and Renovaro and Encourages Investors to Contact the Firm (GlobeNewswire) +12.99% -7.28%
Feb-15-24 09:25AM	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -8.68%
Feb-14-24 10:01AM	Statement of Renovaro Inc (GlobeNewswire) +14.06%
Feb-13-24 09:46AM	Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace (GlobeNewswire) -42.86%
09:31AM	AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine (GlobeNewswire)
Jan-25-24 12:45PM	Renovaro Biosciences Announces Results of Special Meeting of Shareholders (GlobeNewswire) +7.38%
Jan-18-24 09:30AM	Renovaro BioSciences Releases CEO Shareholder Message (NewMediaWire)
Jan-16-24 08:00AM	Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD (GlobeNewswire)
Nov-28-23 08:30AM	Renovaro BioSciences CEO Featured in Recent Proactive Interview (NewMediaWire) -5.83%
Nov-23-23 09:30AM	Renovaro BioSciences Poised to Spearhead Advancements in Battle Against Diseases (NewMediaWire)
Nov-22-23 10:44AM	Renovaro Biosciences CEO unveils potential breakthrough therapies and AI partnerships for 2024 (News Direct)
Nov-21-23 08:30AM	Renovaro BioSciences Eyes Opportunity in Precision Medicine Market (NewMediaWire)
Nov-14-23 09:00AM	Renovaro Biosciences CEO Provides Update on Combination with GEDiCube (NewMediaWire)
Nov-10-23 08:30AM	Renovaro BioSciences, GEDi Cube Combine to Transform Medicine Through AI, Biotherapeutics (NewMediaWire) +5.38%
08:30AM	Loading…
Nov-07-23 08:30AM	Renovaro Biosciences Adds Three New Members to Board as Definitive Agreement with GEDiCube Announced (NewMediaWire)
Oct-24-23 09:00AM	Renovaro BioSciences CEO Provides Insights on Agreement to Combine with GEDi Cube (NewMediaWire) -7.61%
Oct-11-23 09:25AM	Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors (GlobeNewswire) -5.89%
08:30AM	Renovaro BioSciences Announces Board Appointments of Two Finance Experts (NewMediaWire)
Oct-10-23 08:00AM	Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors (GlobeNewswire) +19.08%
Oct-04-23 09:00AM	Renovaro BioSciences CEO Releases Shareholder Letter (NewMediaWire)
Oct-02-23 12:05PM	Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD (GlobeNewswire) +5.15%
09:25AM	AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine (GlobeNewswire)
08:30AM	Renovaro BioSciences Enters Definitive Agreement to Combine with Leading AI Tech GEDi Cube (NewMediaWire)
Sep-29-23 09:15AM	Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine (GlobeNewswire) +9.83%
09:15AM	GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine (Business Wire)
Sep-21-23 03:00PM	Renovaro BioSciences Targets Pancreatic Cancer Through Work With GEDI Cube AI Platform, NVIDIA Resources (NewMediaWire) +13.57%
Sep-19-23 08:30AM	Why Renovaro BioSciences Inc. Is 'One to Watch' (NewMediaWire)
Sep-06-23 12:40AM	Renovaro BioSciences Congratulates GEDiCube on New Joint Effort Clinical Trials (NewMediaWire) -6.98%
Aug-30-23 09:15AM	Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort (GlobeNewswire) +13.08%
Aug-21-23 09:15AM	Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer (GlobeNewswire) +7.78%
Aug-10-23 12:06AM	Renovaro BioSciences, GEDi Cube Announce LOI to Merge, Focus on Fight Against Cancer (NewMediaWire)
Aug-09-23 09:00AM	AI Company GEDi Cube and Renovaro Biosciences Announce a Binding, Exclusive Letter of Intent to Merge, Accelerating Fight Against Cancer (GlobeNewswire) +82.35%
Jul-17-23 07:29AM	3 Doomed Biotech Stocks Destined for Disaster (InvestorPlace) +5.16%
Jun-23-23 05:00PM	Enochian BioSciences Inc. Announces Adjournment of 2023 Annual Stockholder Meeting (GlobeNewswire) -15.73% -13.37%
Jun-08-23 08:45AM	Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review (GlobeNewswire) -6.31%
Apr-03-23 09:00AM	Enochian BioSciences CEO Letter to Shareholders (GlobeNewswire) +10.37%
Mar-29-23 09:00AM	Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher (GlobeNewswire)
Mar-13-23 08:30AM	Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements (GlobeNewswire) +6.54%
Feb-23-23 04:04PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022 (GlobeNewswire) +19.77%
Nov-30-22 05:20PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022 (GlobeNewswire) -22.26%
Oct-26-22 12:01AM	Corrections & Amplifications (The Wall Street Journal) -8.04%
Oct-24-22 08:11PM	Biotech Co-Founder, Facing Murder-for-Hire Charges, Accused of Fabricating Data (The Wall Street Journal) -7.11%
08:00AM	Enochian BioSciences Forges Ahead With Focused Approach, Promising Future (GlobeNewswire)
Oct-21-22 05:00PM	Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K (GlobeNewswire)
Oct-17-22 08:30AM	Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform (GlobeNewswire) +7.34%
Sep-01-22 08:08AM	Enochian Biosciences, Inc. (NASDAQ:ENOB) insiders have significant skin in the game with 49% ownership (Simply Wall St.)
Jul-25-22 10:15AM	Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor (GlobeNewswire) -10.50%
Jul-01-22 08:37PM	Enochian Biosciences Finds Falsified Data in Study of Covid-19 Treatment (The Wall Street Journal) +17.62%
05:00PM	Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data (GlobeNewswire)
Jun-27-22 03:00PM	Biotech Wizard Left a Trail of FraudProsecutors Allege It Ended in Murder (The Wall Street Journal) -21.92%
Jun-10-22 04:00PM	HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Enochian Biosciences (ENOB) Investors with Significant Losses to Contact Firms Attorneys, Firm Investigating Possible Securities Law Violations (ACCESSWIRE) +12.84% -8.20%
Jun-09-22 05:59PM	Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Enochian To Contact Him Directly To Discuss Their Options (ACCESSWIRE) -5.10%
May-31-22 08:00AM	Scientific Leaders Agree on Promise of Enochian BioSciences (GlobeNewswire)
May-25-22 04:20PM	Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company (GlobeNewswire) -36.97% +20.00%
Apr-20-22 07:00AM	Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience (GlobeNewswire)
Apr-07-22 06:00AM	Enochian BioSciences Announces Appointment of Senior Vice President for Clinical Operations with 32 Years Experience at Pfizer (GlobeNewswire) -10.77%
Apr-06-22 09:07AM	Innovative Clinical Strategies to Treat HIV and Cancer Presented by Pioneering Research Scientist at the Innate Killer Summit in San Diego (PR Newswire)
Apr-05-22 06:00AM	Enochian BioSciences Inventor and Co-Founder Presents Data on Novel Clinical Approaches as the Invited, Concluding Plenary Speaker at the Innate Killer Summit (GlobeNewswire)
Mar-25-22 12:07PM	Is Enochian Biosciences, Inc. (NASDAQ:ENOB) Popular Amongst Insiders? (Simply Wall St.)
Mar-15-22 07:00AM	Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans (GlobeNewswire)
Dec-03-21 07:00AM	Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors (GlobeNewswire) -18.64%
Oct-18-21 07:00AM	Enochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month (GlobeNewswire)
Oct-15-21 06:00PM	Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity (GlobeNewswire)
Oct-12-21 06:00PM	Fireside Chat with Enochian BioSciences CEO, Dr. Mark Dybul at H.C. Wainwright 2nd Annual Hepatitis B Virus (HBV) Conference (GlobeNewswire) +5.61% +6.77%
Sep-27-21 07:00AM	Enochian BioSciences Announces Its Successful Completion of FDA Pre-IND for a Potential Cure for Hepatitis B Virus Infection (GlobeNewswire)
Sep-26-21 10:42AM	Is Enochian Biosciences (NASDAQ:ENOB) Using Debt In A Risky Way? (Simply Wall St.)
Sep-13-21 07:00AM	Enochian BioSciences to Present to Investors at the H.C. Wainwright 23rd Annual Investment Conference (GlobeNewswire)
Aug-30-21 07:00AM	Distinguished Scientific and Public Health Leaders to Join Enochian BioSciences Scientific Advisory Board for Potential Inhaled Treatment and Prevention of All COVID-19 and Influenza Variants (GlobeNewswire) +11.29%
Aug-23-21 10:18AM	Distinguished Scientific and Clinical Leader to Join Enochian BioSciences Hepatitis B Cure Scientific Advisory Board (GlobeNewswire) +6.07%
Jul-20-21 07:00AM	Enochian BioSciences Names The Hon. Dr. Mark Dybul as Chief Executive Officer (GlobeNewswire)
Jul-12-21 08:37AM	Enochian Stock Is Trading Higher On FDA Acceptance of Pre-IND Request For Hepatitis B Program (Benzinga)
07:00AM	Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential Cure for Hepatitis B Virus Infection (GlobeNewswire)
05:37AM	Enochian Gains As FDA Agrees To Give View On Potential Cure For Hepatitis B (Investing.com)
Jun-30-21 07:00AM	Enochian BioSciences Announces Scientific Presentation of Elimination of HBV in Mice with No Evident Toxicity (GlobeNewswire)
Jun-21-21 05:31PM	Why Enochian BioSciences Was a Winner on Monday (Motley Fool)
08:03AM	Enochian BioSciences Stock Is Trading Higher After In-Licensing COVID-19, Influenza Inhaled Treatment Technology (Benzinga)
07:00AM	Enochian BioSciences Announces Acquisition of Exclusive License for Potential Pan-Coronavirus and Pan-Influenza Inhaled Treatment and Prevention Technology (GlobeNewswire)
Jun-15-21 09:05AM	Pioneering Research Institute In Los Angeles Moves One Step Closer To Finding A Cure For HIV (PR Newswire) -12.52%
Jun-14-21 03:15PM	Here's Why Enochian BioSciences Stock Skyrocketed Today (Motley Fool) +53.97%
02:53PM	Enochian BioSciences Announces $29 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules (GlobeNewswire)
08:42AM	Mondays Pre-Market: Heres What You Need to Know Before the Market Opens (TipRanks)
07:00AM	Enochian BioSciences Announces FDA Acceptance of Pre-IND Request For Potential HIV Cure (GlobeNewswire)
May-12-21 04:29PM	Enochian BioSciences announces Scientific Presentation of a Person with HIV Exhibiting Controlled Blood Levels of Virus for 255 Days Following Treatment with a Novel Cellular Therapy (GlobeNewswire)
08:05AM	A Promising Approach To HIV Cell Therapy, With Exciting Preliminary Results, Was Presented Recently At The Leading Conference On Gene And Cell Therapy (PR Newswire)

Renovaro, Inc. is a pre-clinical stage biotechnology company, which engages in the development of genetically modified cellular and immune-therapy technologies used for the treatment of infectious diseases and cancer. Its pipeline consists of ENOB-HV-01, ENOB- HV-11, ENOB-HV-12, ENOB-DB-01, ENOB-DC-01, ENOB-DC-11, and ENOB-DC-21. The company was founded by Rene Sindlev and Serhat Gumrukcu on January 18, 2011 and is headquartered in Los Angeles, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
William Anderson Wittekind	10% Owner	Jul 29 '24	Sale	1.30	1,114	1,448	840,319	Oct 24 08:56 AM
William Anderson Wittekind	10% Owner	Jul 17 '24	Sale	1.46	16,362	23,889	841,433	Jul 19 05:44 PM
William Anderson Wittekind	10% Owner	Jul 15 '24	Sale	1.41	21,954	30,955	875,795	Jul 17 04:32 PM
William Anderson Wittekind	10% Owner	Jul 10 '24	Sale	1.51	75,000	113,250	894,645	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 11 '24	Sale	1.51	14,896	22,493	897,749	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 09 '24	Sale	1.53	4,630	7,084	969,645	Jul 15 08:46 AM
William Anderson Wittekind	10% Owner	Jul 05 '24	Sale	1.55	60,000	93,000	974,275	Jul 08 04:50 PM
William Anderson Wittekind	10% Owner	Jul 03 '24	Sale	1.51	50,000	75,500	1,034,275	Jul 08 04:50 PM
William Anderson Wittekind	10% Owner	Jul 01 '24	Sale	1.56	60,000	93,600	1,118,828	Jul 03 07:04 PM
William Anderson Wittekind	10% Owner	Jul 02 '24	Sale	1.54	34,553	53,212	1,084,275	Jul 03 07:04 PM
William Anderson Wittekind	10% Owner	Jun 26 '24	Sale	1.57	50,000	78,500	1,193,499	Jun 27 07:37 PM
William Anderson Wittekind	10% Owner	Jun 25 '24	Sale	1.58	20,000	31,600	1,243,499	Jun 27 07:37 PM
William Anderson Wittekind	10% Owner	Jun 27 '24	Sale	1.50	14,671	22,006	1,178,828	Jun 27 07:37 PM
William Anderson Wittekind	10% Owner	Jun 14 '24	Sale	1.58	50,000	79,000	1,263,499	Jun 18 06:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RENB

Renovaro Inc

Upgrade your FINVIZ experience